Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Market Whispers: Is Molson Coors the Next Big Beverage Buyout?

Molson Coors's strategic expansion into high-growth beverage markets and its undervalued stock price position it as a compelling potential acquisition target.

Target Has Surged in 2026--Wall Street May Be Ready to Hit Pause

Target Has Surged in 2026--Wall Street May Be Ready to Hit Pause

Target shares have rallied in 2026 as its turnaround gains traction, but Wall Street may be hitting pause, waiting on clearer signs the strategy is working.

Blue Owl’s Risk/Reward Profile Is Almost Too Good to Be True

There's a strong argument to be made that Blue Owl’s 65% drop has been completely overcooked, and analysts are calling for as much as 150% upside from here.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Commercial Metals Stock Price Poised to Slingshot Higher in Q3

Commercial Metals Company is on track to rebound robustly in Q2 and Q3 2026 as its business grows and margins widen. Execution is a risk and a catalyst.

Russell 2000 Stocks: Too Early or Finally Interesting?

Russell 2000 stocks may be undervalued as rate cuts loom, with ETFs and names like MWA and AAON offering small-cap upside

Can Capital One Prove Itself in 2026?

Capital One Financial enters 2026 at a critical juncture, as its Discover acquisition and rising credit risks test its ability to deliver sustained growth.

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

inkl

Read news from The Economist, FT, and more,
with one subscription

Financials Are Down Big This Year, but XLF Is Looking Like a Buy-Low Opportunity

Financials Are Down Big This Year, but XLF Is Looking Like a Buy-Low Opportunity

Despite high hopes for financials during Trump’s second term, the sector has performed the worst in the S&P 500 this year. But the XLF offers a buy-low entry.

Affirm: A Solid Footing or More Volatility Ahead?

Affirm: A Solid Footing or More Volatility Ahead?

Affirm stock is gaining attention as the buy-now-pay-later lender shows growth and improving profitability, but risks remain in credit quality and competition.

Why It's Not Time to Give Up on the Gold Trade

Why It's Not Time to Give Up on the Gold Trade

Gold’s pullback may be temporary as rising U.S. debt, inflation risks, and geopolitical tensions support a longer-term bullish outlook

Dividend Resilience: Why These Kings Are Safe After a Volatile Q1

Dividend Resilience: Why These Kings Are Safe After a Volatile Q1

In a volatile market, many investors are turning to these Dividend Kings that offer reliable income, strong balance sheets, and stability

Cintas Corporation: The Deep Value Opportunity in Plain Sight

Cintas Corporation: The Deep Value Opportunity in Plain Sight

Cintas is a cash-flow machine, paying dividends, buying shares, investing in growth, and maintaining financial independence.

Is Oracle the First of the AI Bubbles to Pop?

Is Oracle the First of the AI Bubbles to Pop?

Oracle’s 60% drop may look like the AI hype is unwinding, but bullish analyst sentiment suggest the selloff may have gone too far.

MarketBeat Week in Review – 03/23 - 03/27

Stocks were down sharply this week as geopolitical risk elevates concerns about higher inflation and interest rates despite a temporary pause in hostilities

Get all your
news in one place.

100's of premium titles.
One news app.

Braze Stock Rallies as Revenue Beats, Buybacks Begin, and Outlook Jumps

Braze, Inc. is rebounding after a hot report affirms its growth outlook. AI disruptions are good for this business and driving profits.

Karman Tanks 14%: Opportunity or Warning for This Defense Darling

Following a standout 2025, defense newcomer Karman just took a huge post-earnings hit. Still, amid "generational" demand, KRMN remains confident in its future.

Ondas Inc. Flywheel Gains Momentum, Vertical Liftoff Imminent

Ondas Inc. is gaining momentum, accelerating business, and is on track to profitability. Headwinds are easing, and stock price liftoff is imminent.

KB Home's Earnings Slump Puts Dividends and Buybacks at Risk

KB Home is a high-quality stock experiencing a low-quality period, with capital returns at risk and lower stock prices likely.

Get all your
news in one place.

100's of premium titles.
One news app.

Big Tech Just Got Hit—Why This Lawsuit Could Change Social Media Forever

Though the damages from the recent social media trial involving Meta and Google are in the millions, the potential implications are much larger.

Chewy Gobbles up Market Share in 2026: Poised to Advance in Q2

Chewy is on track to rebound in 2026 as optimistic earnings guidance keeps analysts interested. Institutions are a risk but may revert to accumulation in Q2.

How Maven Turns Palantir's Biggest Risk Into Its Biggest Strength

Palantir’s Maven program is now a Pentagon system of record, turning government dependency into durable growth and strengthening PLTR’s long-term outlook

Quiet BNY and Northern Trust Reward Patient Investors

Custodian bank stocks like BNY Mellon and Northern Trust offer steady income, durable advantages, and exposure to the financial system’s vital infrastructure.

Smithfield Foods Roasts Q4 Estimates: Is a $30 Price Handle Near?

Smithfield Foods is on track to hit new highs amid growth, margin expansion, dividend increases, and bullish analyst activity.

5 April Buys With Double-Digit Year-End Targets

Tech stocks are poised to rebound after hitting deeply oversold levels early in 2026. Analysts and institutional trends align; double-digit upside is ahead.

What’s in a Name? Shoe Carnival Plans Rebrand as 2026 Guidance Resets Expectations

Shoe Carnival stock falls after weak 2026 guidance overshadows Q4 results, even as its Shoe Station pivot and valuation offer long-term appeal.

1 … 7 8 9 10

People

181,478 stories

Michael Fiddelke

Jeffrey Neal Johnson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Advanced Micro Devices

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

362,184 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play